Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Charly50on Jan 12, 2022 5:39am
326 Views
Post# 34306846

Long overdue

Long overdue
You have already mentioned the reasons for the fall in the share price:
>selling of good news, the short term have also 
   got out again in the short term
>the deliberate manipulation of the share price through a targeted large 
  sell order with the aim of triggering the stop orders and creating a 
  chain reaction.
>coupled with short selling
>I believe that these points are interrelated.
 
A weak act that the people in charge around LJ/Canncord.
have not found an adequate means to counteract, and also gstern at the beginning.
were only spectators.  They have lost tremendously in confidence, but made themselves the Tasxhen again full. Hellhounds.
I am pissed off! ! Who tells us that it will not happen a 
3rd time happens??
 
I owe it to my investor instinct and have added at 1.50.
Is there much more behind it. has it been a palnte manipulation to get to STckzahlen.
I can imagine it.
I think the medical and scientific data were good.
(Actually, these were also expected and the 7th patient question has been answered).
 
PT now has the onus on them to deliver.
 
I hope he has a timeline. Philip should be aware that he has to be patient
of the collective shareholders. It is time, above time; it is overdue to follow news with substance (license deal).
 
<< Previous
Bullboard Posts
Next >>